AAV case study: 3X titer with integrated clarification
AAV case study: 3X titer with integrated clarification
Two case studies illustrate multi-fold upstream AAV titer increases for viral vector from HEK293 cells. In addition to productivity gains, XCell™ and TFDF® technologies clarify conditioned media for manufacturing operational simplicity. Product yield and process economics in the context of the current viral vector supply demand gap will be discussed.
Nov 01
Discover More Webinars
01
02
03
04
05
01
/
05
ウェビナー
Automating the UF/DF Process with In-Line Concentration Measurement to Reduce Cycling Time and Accelerate PD
8年5月
ウェビナー
Innovative, differentiated technologies advancing new modalities: Case studies in mRNA & viral vectors
Feb 23
ウェビナー
ウェビナー
ウェビナー
Disruptive technologies transforming upstream process intensification for all modalities
Feb 2
11:00 EDT